Ospedale dei Bambini V. Buzzi Milano Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT03042624
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Pediatrics Department Ospedale dei Bambini V. Buzzi Milano

Active Ingredients

Drugs in Other Trials (2)

maltodextrin (1 trial)

oryza sativa (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2